Alkimiya
Alkimiya SRL is an Italian digital-health startup headquartered in Rome that builds and distributes clinical decision support systems grounded in Evidence Based Medicine. It is the exclusive Italian distributor of EBMEDS, a third-generation CDSS owned by Duodecim Publication Company of Finland carrying more than 1,000 clinical algorithms for drug interaction, contraindication, dosage and medication-reconciliation checking. Alkimiya is also developing SmartCare, its own Digital Clinical Decision Pathway platform for the proactive support of post-discharge and chronic patients, combining an evidence-based knowledge base, a rules engine and an integration API meant to make telemedicine systems and electronic health records act on clinical guidance. Continuum of Care packages the same pathway engine as cloud SaaS with patient-facing mobile apps. The company markets the SmartCare API but publishes no developer portal, reference or machine-readable contract.
Alkimiya is profiled on the APIs.io network. Tagged areas include Company, Health, Healthcare, Clinical Decision Support, and Evidence Based Medicine.
Alkimiya’s developer surface includes support, engineering blog, and 7 more developer resources.
Kin Score
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Alkimiya Rate Limits
RATE LIMITSSecurity Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 1
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.